Accounts Receivable Analyst, Order- to- Cash
stream:bsky-jetstream 9d ago
NEW YORK, Sept.
NEW YORK, Sept.
Six SEC regulatory filings were submitted July 23-24, 2026, by unrelated companies including Scribe Therapeutics, Artiva Biotherapeutics, Doximity, Gossamer Bio, and TCG Crossover GP II. The filings cover routine insider holdings disclosures (Forms 3 and 4) and amended beneficial/institutional ownership reports (Schedules 13D/A and 13G/A).
Pathology has become one of the most important foundations of modern healthcare, supporting accurate diagnosis, research development, and improved treatment strategies. With continuous advancements in medical science.